| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.004 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.091 | 0.005 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.005 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |